Indian Journal of Ophthalmology

ORIGINAL ARTICLE
Year
: 1994  |  Volume : 42  |  Issue : 1  |  Page : 31--35

Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin


Atul Kumar, HK Tewari, DP Bathwal, PK Khosla 
 Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi, India

Correspondence Address:
Atul Kumar
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, Ansari Nagar, New Delhi 110 029
India

Proliferative vitreoretinopathy (PVR) remains the most common cause of failure in retinal detachment surgery. Surgical procedures for its repair entails complex and extensive instrumentation besides technical skill. The success rate varies widely with high incidence of redetachment. Keeping this in view, we evaluated the role of intravitreal daunorubicin as an anti-mitiotic agent in the inhibition of PVR. Our study concluded that 5 micrograms of intravitreal daunorubicin effectively inhibited PVR in the rabbit eye and the dosage was safe and nontoxic. The half-life of the drug was determined to be about 140 minutes, suggesting a prolonged intravitreal concentration sufficient to prevent fibroblast proliferation


How to cite this article:
Kumar A, Tewari H K, Bathwal D P, Khosla P K. Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin.Indian J Ophthalmol 1994;42:31-35


How to cite this URL:
Kumar A, Tewari H K, Bathwal D P, Khosla P K. Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin. Indian J Ophthalmol [serial online] 1994 [cited 2022 Jan 25 ];42:31-35
Available from: https://www.ijo.in/article.asp?issn=0301-4738;year=1994;volume=42;issue=1;spage=31;epage=35;aulast=Kumar;type=0